Gantonoc, Gerve B.
HRN: 18-29-92 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2024
OXACILLIN 500MG (VIAL)
08/08/2024
08/15/2024
IV
2g
Q6h
TBI SEVER
Waiting Final Action